Viewing Study NCT01391403


Ignite Creation Date: 2025-12-24 @ 7:22 PM
Ignite Modification Date: 2025-12-28 @ 6:02 PM
Study NCT ID: NCT01391403
Status: COMPLETED
Last Update Posted: 2016-07-12
First Post: 2011-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia
Sponsor: Beijing HuiLongGuan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module